Moreover, the Kaplan–Meier analysis showed that the survival of patients with glioma in the high-MELK expression group was obviously poorer than that in the low-MELK expression group (HR = 2.38, 95% CI = 1.47–3.87, P <v 0.001) (Figure 9E). The gene discussed is MELK; the disease is central nervous system cancer.